Compare Modern Chinese Medicine Group Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- The company is Net-Debt Free
2
With a fall in Net Sales of -26.46%, the company declared Very Negative results in Dec 25
3
With ROE of -2.68%, it has a Very Expensive valuation with a 1.56 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
HKD 871 Million ()
NA (Loss Making)
NA
0.00%
-0.46
-2.68%
1.57
Revenue and Profits:
Net Sales:
105 Million
(Quarterly Results - Dec 2020)
Net Profit:
13 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-66.54%
0%
-66.54%
6 Months
26.09%
0%
26.09%
1 Year
33.85%
0%
33.85%
2 Years
148.57%
0%
148.57%
3 Years
77.55%
0%
77.55%
4 Years
81.25%
0%
81.25%
5 Years
-7.45%
0%
-7.45%
Modern Chinese Medicine Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-22.41%
EBIT Growth (5y)
-160.21%
EBIT to Interest (avg)
74.28
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.69
Tax Ratio
3.42%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
42.19%
ROE (avg)
14.49%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.56
EV to EBIT
-33.79
EV to EBITDA
-113.32
EV to Capital Employed
2.04
EV to Sales
3.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.02%
ROE (Latest)
-2.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'20 - YoY
Dec'20
Dec'19
Change(%)
Net Sales
105.10
50.90
106.48%
Operating Profit (PBDIT) excl Other Income
28.30
15.70
80.25%
Interest
0.10
0.00
Exceptional Items
-7.30
-13.10
44.27%
Consolidate Net Profit
12.60
5.90
113.56%
Operating Profit Margin (Excl OI)
264.20%
300.20%
-3.60%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2020 is 106.48% vs -3.96% in Dec 2019
Consolidated Net Profit
YoY Growth in quarter ended Dec 2020 is 113.56% vs -61.94% in Dec 2019
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
157.40
232.10
-32.18%
Operating Profit (PBDIT) excl Other Income
-5.20
36.00
-114.44%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-14.70
10.50
-240.00%
Operating Profit Margin (Excl OI)
-113.00%
111.70%
-22.47%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -32.18% vs -38.95% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -240.00% vs -80.52% in Dec 2024
About Modern Chinese Medicine Group Co., Ltd. 
Modern Chinese Medicine Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






